Trials.AI

Enhancing the impact of clinical trials involves a strategic blend of technology, data, and human experience. This approach aims to accelerate change in clinical research by addressing key challenges in clinical trials.

Key Challenges in Clinical Trials

• Digital and Technology Transformation: Develop adaptable technology for any IT ecosystem, focusing on scalability and innovation.
• AI Integration: Enhance the AI capabilities within clinical research organizations to improve planning and execution.
• Portfolio Strategy: Navigate the rapid changes in clinical development with a focus on patient experience and virtual technology integration.
• Protocol Design: Overcome data silos to prioritize investments and optimize study design.
• Program Planning: Predict trial success globally, engaging the right sites and investigators to mitigate risks and ensure quality.
• Study Execution and Data Collection: Organize data globally and identify performance drivers for real-time study modifications.

ZS's Approach

ZS partners with R&D leaders and clinical research organizations to enhance clinical development through thoughtful design, trial differentiation, and predictive modeling. This collaboration aims to deliver greater value to patients and transform the drug pipeline.

Features and Benefits

• Trial Design Optimization: Utilize a virtual Clinical Design Center for cross-functional collaboration, powered by AI, to expedite trial planning and execution.
• Quality and Risk Management: Monitor and predict clinical development risks effectively.
• Human-Centric Trials: Evaluate trial stakeholders to understand their values and improve engagement.
• Biometrics and Data Solutions: Modernize infrastructure to enhance data management and biostatistics.
• Digital and Decentralized Trials: Support clinical trial programs with a comprehensive ecosystem of solutions.
• Diversity, Equity, and Inclusion: Foster a diverse and inclusive clinical development environment through patient insights.

Furthermore, the platform supports seamless data flow in clinical trials, enabling standards-driven data pipelines. It also promotes the use of in silico trials, allowing for smarter and faster clinical trials through simulation-first methods.

Overall, the future of drug development is centered on eliminating guesswork, removing barriers, and delivering therapeutic innovations more efficiently and cost-effectively.